Skip to main navigation Skip to search Skip to main content

Serum high-mobility group box-1 levels are positively associated with micro- and macroalbuminuria but not with cardiovascular disease in type 1 diabetes: the EURODIAB Prospective Complications Study

  • Jwm Nin*
  • , I Ferreira
  • , Cg Schalkwijk
  • , Mh Prins
  • , N Chaturvedi
  • , Jh Fuller
  • , Cda Stehouwer
  • , Eurodiab Prospective Complication Study
  • , Angelo Maria Minnella
  • *Corresponding author

Research output: Contribution to journalArticle

10   Link opens in a new tab Citations (SciVal)

Abstract

High-mobility group box-1 (HMGB1) is a pro-inflammatory cytokine that may contribute to the pathogenesis of micro- and macrovascular complications commonly observed in diabetes. We investigated whether HMGB1 is associated with: i) markers of low-grade inflammation (LGI) and endothelial dysfunction (ED) and pulse pressure (PP, a marker of arterial stiffness); ii) prevalent nephropathy, retinopathy and cardiovascular disease (CVD) in type 1 diabetes; and iii) the potential mediating roles of LGI, ED and PP therein.
Original languageEnglish
Pages (from-to)325-332
Number of pages8
JournalEuropean Journal of Endocrinology
Volume166
Issue number2
DOIs
Publication statusPublished - 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Keywords

  • Adult
  • Albuminuria
  • Biological Markers
  • Cardiovascular Diseases
  • Case-Control Studies
  • Cross-Sectional Studies
  • Diabetes Complications
  • Diabetes Mellitus
  • Europe
  • Female
  • Glomerular Filtration Rate
  • HMGB1 Protein
  • Humans
  • Male
  • Middle Aged
  • Risk Factors
  • Severity of Illness Index
  • Type 1

Fingerprint

Dive into the research topics of 'Serum high-mobility group box-1 levels are positively associated with micro- and macroalbuminuria but not with cardiovascular disease in type 1 diabetes: the EURODIAB Prospective Complications Study'. Together they form a unique fingerprint.

Cite this